Mutant H-ras overexpression inhibits drug and U.V. induced apoptosis

Anticancer Research

Volumn 16, Issue 4 A, 1996, Pages 1691-1705

  Fernandes, Richard S ^a   Mcgowan, Adrian J ^a   Cotter, Thomas G ^a  

^a UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

Apoptosis; Catalase; Peroxides; Ras

Indexed keywords

ANTINEOPLASTIC AGENT; ANTIOXIDANT; CAMPTOTHECIN; CATALASE; DACTINOMYCIN; ENDONUCLEASE; ETOPOSIDE; PEROXIDE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; ENZYME ACTIVITY; FIBROBLAST; GENE EXPRESSION; GENE MUTATION; GENETIC TRANSFECTION; NONHUMAN; ONCOGENE H RAS; PRIORITY JOURNAL; RAT; TUMOR SUPPRESSOR GENE; ULTRAVIOLET IRRADIATION;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CAMPTOTHECIN; CELL LINE; DACTINOMYCIN; DNA; ETOPOSIDE; FIBROBLASTS; FLOW CYTOMETRY; GENE EXPRESSION; GENES, RAS; HUMANS; KINETICS; MUTAGENESIS; RATS; TIME FACTORS; ULTRAVIOLET RAYS;

EID: 0029738762     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Duvall E and Wyllie AH: Cell death: The significance of apoptosis. Int RevCytol 68: 251-306, 1986.
2. Soumitra S: Programmed cell death: concept, mechanism and control. Biol Rev 67: 287-319, 1992.
3. Shi Y, Szalay MG, Paskar L, Boyer M, Singh B and Green DR: Activation - induced cell death in T cell hybridomas is due to apoptosis. Morphologic aspects and DNA fragmentation. J Immunol 144: 3326-3331, 1990.
4. Truman JW and Schwartz LM: Programmed death in the nervous systems of a moth. Trends in Neuroscience 5: 270-273,1982.
5. Sachs L and Lotem J: Control of programmed cell death in normal and leukemic cells: new implications for therapy. Blood 82: 15-21, 1993.
6. Ellis R.E, Yaun J and Horvitz HR: Mechanisms and functions of cell death. Annu Rev Cell Biol 7: 663-698,1991.
7. 0 to G1. Nature 328: 445-449, 1987.
8. Dalla-Favera R, Martinotti S, Gallo RC, Erikson J and Croce CM: Translocation and rearrangements of the c-myc oncogene locus in human undifferentiated B-cell Iymphomas. Science 219: 963-967, 1983
9. Evan GI, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brooks M, Waters CM, Penn LZ and Hancock DC: Induction of apoptosis in fibroblasts by c-myc protein. Cell 69: 119-128,1992.
10. Fanidi A, Harrington EA and Evan GI: Interaction between c-myc and bcl-2 proto-oncogenes: a novel paradigm for oncogene cooperation. Nature 359: 554-556, 1992.
11. Hockenbery DM, Oltvai ZN, Yin X-M, Milliman CL and Korsmeyer SJ: Bcl-2 functions in an Antioxidant pathway to prevent apoptosis. Cell 75: 241-251, 1993.
12. Evans CA, Owen PJ, Whetton AD and Dive C: Activation of the Abelson tyrosine kinase activity is associated with the suppression of apoptosis in haemopoietic cells. Cancer Res 53: 1735-1738, 1993.
13. Bos JL: Ras oncogenes in human cancer. A review. Cancer Res 49: 4682-4689, 1989.
14. ras. TIBS 18: 250-254, 1993.
15. Wyllie AH, Rose KA, Morris RG, Steel CM, Foster E and Spandidos DA: Rodent fibroblast tumours expressing human myc and ras genes: Growth, metastasis and endogenous oncogene expression. Br J Cancer 56: 251-259, 1987.
16. Arends MJ, McGregor AH, Toft NJ, Brown EJH and Wyllie AH: Susceptibility to apoptosis is differentially regulated by c-myc and mutated Ha-ras oncogenes and is associated with endonuclease availability. Br J Cancer 68: 1127-1133, 1993.
17. Moore J, Boswell S, Hoffman R, Burgess G and Hromas R: Mutant H-ras overexpression inhibits a random apoptotic nuclease in myeloid leukemia cells. Leukemia Res 17: 703-709, 1993.
18. Cohen JJ, Duke RC, Fadok VA and Sellins KS: Apoptosis and programmed cell death in immunity. Annu Rev Immunol 10: 267-293, 1992.
19. Gorczyca W, Bruno S, Darzynkiewicz RJ, Gong J and Darzynkiewicz Z: DNA strand breaks occurring during apoptosis: Their early in-situ detection by the terminal deoxynucleotidyl transferase and nick translation assays and prevention by serine protease inhibitors. Int J Oncology 1: 639-648, 1992.
20. + thymocytes by flow cytometry. J Immunol methods 137: 79-87, 1991.
21. Nieto MA and Lopez-Rivas A: IL-2 protects T-lymphocytes from glucocorticoid induced cell death. J Immunol 143: 4166-4170, 1989.
22. Aeibi H: Catalase in vitro. Methods in Enzymology 105: 121-130,
23. Lennon SV, Martin SJ and Cotter TG: Dose dependent induction of apoptosis in human tumour cell lines by widely diverging stimuli. Cell Prolif 24: 203-214, 1991.
24. Fernandas RS and Cotter TG: Activation of a calcium, magnesium independent endonuclease in human leukemic cell apoptosis. Anticancer Res 13: 1253-1260, 1993.
25. Verhaegen S, McGowan AJ, Brophy AR, Fernandes RS and Cotter TG: Inhibition of apoptosis by anti-oxidants in the human HL-60 leukemia cell line. Biochem Pharmacol 50: 1021 -1029, 1995.
26. Servomaa K and Rytomaa T: Suicidal death of rat chloroleukaemia cells by activation of the long interspersed repetitive DNA element (LIRn). Cell Tissue Kinet 21: 33-43,1988.
27. Andrejauskas E and Moroni C: Reversible abrogation of IL-3 dependence by an inducible H-ras oncogene. EMBO J 8: 2575-2581, 1989.
28. Perchellet EM, Maatta EA, Abney NL and Perchellet JP: Effect of diverse intracellular thiol delivery agents on glutathione peroxidase activity, the ratio of reduced / oxidized glutathione, and ornithine decarboxylase induction in isolated mouse epidermal cells treated with 12-0-tetradecanoylphorbol-13-acetate. J Cell Physiol 131: 6471, 1987.